Study Offers Reassurance on Inhaled Corticosteroid Use for Asthma in Pregnancy
(MedPage Today) -- Women with asthma who continued taking inhaled corticosteroids during the first trimester of pregnancy did not suffer higher rates of adverse outcomes compared with those who discontinued use, a South Korean nationwide cohort...
A recent South Korean study provides reassurance for women with asthma who continue taking inhaled corticosteroids (ICS) during the first trimester of pregnancy. The nationwide cohort study found no significant differences in adverse outcomes for mothers or their babies when comparing those who continued ICS use versus those who stopped.
Risk ratios for major complications, such as gestational diabetes, preeclampsia, preterm birth, low birth weight, and congenital malformations, were all close to 1.0, indicating no increased risk associated with continued ICS use. The findings held true even after accounting for potential confounding factors and in various subgroup analyses.
While the study's results provide reassurance, researchers emphasize that each patient's asthma should still be managed on an individual basis.
Written by urgent.news from MedPage Today's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
